ArticleInternational journal of transgender health2026
The evolution of pediatric transgender healthcare in Flanders: Trends in referrals, intakes and gender-affirming interventions over the last 15 years.
Article in International journal of transgender health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of gender-affirming hormone therapy from adolescence to adulthood on cardiovascular function: a cross-sectional study.Frontiers in endocrinology · 2026Article
- The gender incongruence module in the European Registries for Rare Endocrine & Bone Conditions (EuRREB): first results, current insights, and future directions.Endocrine connections · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The expanding number of minors questioning their gender identity and seeking care has led to the constitution of pediatric gender clinics in several countries. The activity of the multidisciplinary Pediatric Gender Team at Ghent University Hospital, Belgium started in 2007. We report on the evolution of referrals, psychological intakes, and trends in the start of gender-affirming medical and surgical interventions from 2007 to 2023. Methods: The whole cohort of minors (age <17 years) having a psychological intake between 2007 and 2023 was included. Subgroups were analyzed based on sex registered at birth (female or male, RFAB and RMAB respectively), year and age at the psychological intake (below or above 10 years). Results: Referrals have increased in recent years. Between 2007 and 2023, 890 minors (65.5% RFAB) accessed our service. The ratio RFAB/RMAB has progressively increased, and RFAB with age at first intake >10 represented the greatest proportion. After 12 months, 19.5% were no longer in follow-up at our center; 28.1% of RFAB and 47.2% of RMAB did not start any medical treatment; 66.9% of RFAB and 52.8% of RMAB started gonadal hormone suppression (GHS), achieved with gonadotropin-releasing hormone analogues in 17.7% of RFAB and 34.6% of RMAB, with pro-androgenic progestins in 82.3% of RFAB and with anti-androgens in 65.4% of RMAB. 74.6% of RFAB and 86.4% of RMAB on GHS and older than 16 started gender-affirming hormones. Mastectomy was the most common gender-affirming surgery in RFAB, followed by hystero-gonadectomy. Gender-affirming surgery in RMAB was less frequent; vaginoplasty was the most frequent procedure. Conclusions: The care of minors with gender incongruence requires a multidisciplinary approach due to the complex psychological, social, and physical needs of this group. The timing and therapeutical options must be tailored to each adolescent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.